Breast Cancer: Achievements in Adjuvant Systemic Therapies in the Pre-Genomic Era
Author:
Affiliation:
1. a S.C. Oncologia Medica, Azienda Ospedaliera, Perugia, Italy
2. b Medical Oncology Clinic, Jules Bordet Institute, Brussels, Belgium
Abstract
Publisher
Oxford University Press (OUP)
Subject
Cancer Research,Oncology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1634/theoncologist.11-2-111
Reference115 articles.
1. Ovarian ablation in early breast cancer: overview of the randomised trials;Early Breast Cancer Trialists' Collaborative Group;Lancet,1996
2. Polychemotherapy for early breast cancer: an overview of the randomised trials;Early Breast Cancer Trialists' Collaborative Group;Lancet,1998
3. Tamoxifen for early breast cancer: an overview of the randomised trials;Early Breast Cancer Trialists' Collaborative Group;Lancet,1998
4. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials;Early Breast Cancer Trialists' Collaborative Group;Lancet,2005
5. Bethesda, Maryland, USA. November 1–3, 2000. Proceedings;The National Institutes of Health Consensus Development Conference: Adjuvant Therapy for Breast Cancer;J Natl Cancer Inst Monogr,2001
Cited by 51 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Targeted therapy of breast tumor by PLGA-based nanostructures: The versatile function in doxorubicin delivery;Environmental Research;2023-09
2. Personalized medicine in breast cancer: pharmacogenomics approaches;Pharmacogenomics and Personalized Medicine;2019-05
Personalized medicine in breast cancer: pharmacogenomics approaches
3. Use of Systemic Therapy Concurrent With Cranial Radiotherapy for Cerebral Metastases of Solid Tumors;The Oncologist;2017-02-01
4. Harnessing benefit from targeting tumor associated carbohydrate antigens;Human Vaccines & Immunotherapeutics;2016-12-08
5. SiO2 nanoparticles modified CPE as a biosensor for determination of i-motif DNA/Tamoxifen interaction;International Journal of Biological Macromolecules;2016-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3